论文信息 - Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer) - 字舞流文

Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)

M. Stockler | J. Kench | L. Horvath | P. Stricker | L. Butler | M. Centenera | A. Joshua | K. Mahon | N. Ahmadi | R. Thanigasalam | H. Woo | L. Sebastian | T. Scheinberg